Legal Opinion Letters

March 24, 2006

Legal Opinion Letters

Advertising And Preemption Under FDA’s New Drug Labeling Rule

Download the PDF

By Tish E. Pahl, a principal with Olsson, Frank and Weeda, P.C.

Related Content

Counsel’s Advisories

January 27, 2006

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

By James Dabney Miller, a partner in the Washington, D.C. office of the law firm King & Spalding LLP.

Legal Opinion Letters

February 20, 2004

FDA Guidance for “DTC” Ads Strives To Advance Consumer Understanding

By <a href="http://www.wrf.com/attorney/bio.asp?ID=H582744778" target="_blank" Rosemary C. Harold, a partner with the Washington, D.C. law firm Wiley Rein & Fielding LLP, and <a href="http://www.wrf.com/attorney/bio.asp?ID=K458416164" target="_blank"John F. Kamp, a counsel to the firm.